US Codex
C.F.R.
Browse by date
Notes

§866.3940. West Nile virus serological reagents.

21 C.F.R. § 866.3940

(a)
Identification. West Nile virus serological reagents are devices that consist of antigens and antisera for the detection of anti-West Nile virus IgM antibodies, in human serum, from individuals who have signs and symptoms consistent with viral meningitis/encephalitis. The detection aids in the clinical laboratory diagnosis of viral meningitis/encephalitis caused by West Nile virus.
(b)
Classification. Class II (special controls). The special control is FDA's guidance entitled “Class II Special Controls Guidance Document: Serological Reagents for the Laboratory Diagnosis of West Nile Virus.” See § 866.1(e) for the availability of this guidance document.
Notes, amendments, and revision history

Amendments

[68 FR 61745, Oct. 30, 2003]

Authority

Authority: 21 U.S.C. 351, 360, 360c, 360e, 360j, 360 l, 371.

Source

Source: 47 FR 50823, Nov. 9, 1982, unless otherwise noted.

Amendments

[68 FR 61745, Oct. 30, 2003]